Referencing a Stat online report, MSN identifies three finalists to replace Marty Makary as FDA commissioner.
CDER and CBER continue to experience net workforce losses through the first nine months of fiscal year 2026, although hiring improved during the third quarter, new FDA data show.
Referencing a Stat online report, MSN identifies three finalists to replace Marty Makary as FDA commissioner.
CDER and CBER continue to experience net workforce losses through the first nine months of fiscal year 2026, although hiring improved during the third quarter, new FDA data show.
Krieger Scientific CEO Joseph Morwald says a 59% increase in FDA drug Warning Letters in 2025 over 2024 should be seen by industry as a diagnosis of a structural issue rather than isolated mistakes.
A Capitol Hill hearing next week examines how FDA can help strengthen the nation's leadership in biomedical innovation.
